Real-world evidence: the future is here
Use of real-world evidence (RWE) in the pharmaceutical industry is becoming increasingly common. It aids the clinical development process and provides important data for pricing discussions once medicines have been approved. With that in mind, PharmaPhorum’s Richard Staines spoke with Aetion President and Chief Science Officer Jeremy Rassen about how data obtained from outside the traditional randomized controlled trial setting is transforming drug research. Rassen defines real-world data as data that represents the actual experience that patients have with the medications that they have been taking....